STUDY OF SERUM ACID URIC LEVEL IN KIDNEY TRANSPLANTATION PATIENTS AT BACH MAI HOSPITAL

Thị An Thủy Nguyễn1, Trung Dũng Nghiêm 2,
1 HMU
2 Bach Mai hospital

Main Article Content

Abstract

Objective: (1) Evaluation of serum acid uric (AU) level in renal transplantation patients at Bach Mai hospital. (2) Study of the relationship between serum acid uric level with some clinical and subclinical factors at this group patient. Subjects and Methods: a cross-sectional descriptive of 346 patients after kidney transplantation at the outpatient kidney transplant clinic- at Bach Mai Hospital from April 2022 to October 2022. Results: The percentage of hyperuricemia in 346 patients after kidney transplantation followed up at the Outpatient Kidney Transplant clinic- at Bach Mai Hospital was 49.4%. This ratio in woman is similar to men. The most common age group to increase serum AU level is 30 – 39 years old. The status of increased serum AU level was seen at a higher rate in the group with a time of 1-3 years after kidney transplant (62.5%, statistically significant difference compared with the transplant group less than 1 year or more than 3 years). The rate of increased serum AU level in the group with dyslipidemia and the group without ACE/ARB was statistically significantly higher than in the group without dyslipidemia and the ACE/ARB group respectively. The mean GFR in the group with hyperuricemia was statistically significantly lower than that in the group with normal serum AU levels (p < 0.05). Conclusion: Attention to assessment and treatment of hyperuricemia in patients after kidney transplantation is an important factor contributing to maintaining stable long-term kidney transplant function.

Article Details

References

1. Haririan A, Metireddy M, Cangro C, et al. Association of Serum Uric Acid With Graft Survival After Kidney Transplantation: A Time-Varying Analysis: Uric Acid and Kidney Transplantation. American Journal of Transplantation. 2011; 11(9):1943-1950.
2. Isakov O, Patibandla BK, Shwartz D, Mor E, Christopher KB, Hod T. Can uric acid blood levels in renal transplant recipients predict allograft outcome? Renal Failure. 2021; 43 (1):1240-1249.
3. Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients. American Journal of Transplantation. 2009; 9(s3):S1-S155.
4. James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014; 311(5):507-520.
5. American Diabetes Association. 2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020. Diabetes Care. 2020; 43(Suppl 1):S14-S31.
6. Fedder DO, Koro CE, L’Italien GJ. New National Cholesterol Education Program III guidelines for primary prevention lipid-lowering drug therapy: projected impact on the size, sex, and age distribution of the treatment-eligible population. Circulation. 2002; 105(2):152-156.
7. KDIGO Evaluation and Management of Chronic Kidney Disease Guideline Summary. Accessed March 18, 2022. https: //www.guidelinecentral.com/guideline/25092/
8. Lê Việt Thắng, Nguyễn Đức Lộc, Đào Bùi Quý Quyền. Khảo sát yếu tố độc lập tiên lượng tăng nồng độ CRP-hs và Acid uric huyết tương ở bệnh nhân sau ghép thận. Tạp chí Nội khoa Việt Nam. 2020:18:38-43.
9. Min SI, Yun IJ, Kang JM, et al. Moderate-to-severe early-onset hyperuricaemia: a prognostic marker of long-term kidney transplant outcome. Nephrology Dialysis Transplantation. 2009; 24 (8):2584-2590.
10. Stamp LK, Day RO, Yun J. Allopurinol hypersensitivity: investigating the cause and minimizing the risk. Nat Rev Rheumatol. 2016; 12(4):235-242.